Jesse Neri
Financieel Directeur/CFO bij ROCKWELL MEDICAL, INC.
Vermogen: 50 328 $ op 30-04-2024
Actieve functies van Jesse Neri
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. | Financieel Directeur/CFO | 18-10-2023 | - |
Loopbaan van Jesse Neri
Eerdere bekende functies van Jesse Neri
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ZYLA LIFE SCIENCES | Corporate Officer/Principal | 01-06-2015 | - |
Opleiding van Jesse Neri
| Villanova University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Director of Finance/CFO | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
- Beurs
- Insiders
- Jesse Neri
- Ervaring
